Gunji Nagatani

Transcription factor Y-box binding protein 1 binds preferentially to cisplatin-modified DNA and interacts with proliferating cell nuclear antigen.

Tomoko Ise, Gunji Nagatani, Toshihiro Imamura et al. · PubMed · 1999 · 175 citations

Cisplatin-modified Dna, Tumor Biology, Transcriptional Regulation +20

Interaction with p53 Enhances Binding of Cisplatin-modified DNA by High Mobility Group 1 Protein

Toshihiro Imamura, Hiroto Izumi, Gunji Nagatani et al. · Journal of Biological Chemistry · 2001 · 102 citations · Full text

Transcriptional activation of the human HMG1 gene in cisplatin-resistant human cancer cells.

Gunji Nagatani, Minoru Nomoto, Hiroshi Takano et al. · PubMed · 2001 · 62 citations

Cisplatin-modified Dna, Genetics, Cancer Biology +19

Physical interaction of tumour suppressor p53/p73 with CCAAT-binding transcription factor 2 (CTF2) and differential regulation of human high-mobility group 1 (HMG1) gene expression

Hidetaka Uramoto, Hiroto Izumi, Gunji Nagatani et al. · Biochemical Journal · 2003 · 58 citations · Full text

Gccaat Recognition Sites, Genetics, Physical Interaction +20

p300/CBP-associated factor (P/CAF) interacts with nuclear respiratory factor-1 to regulate the UDP-N-acetyl-alpha-d-galactosamine: polypeptide N-acetylgalactosaminyltransferase-3 gene

Hiroto Izumi, Ryo Ohta, Gunji Nagatani et al. · Biochemical Journal · 2003 · 51 citations · Full text